
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 89
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 89
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
Taiyu Shang, Tianyi Jiang, Tao Lü, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Taiyu Shang, Tianyi Jiang, Tao Lü, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy
Luyao Tian, Xia Li, Lanping Guo, et al.
Coordination Chemistry Reviews (2024) Vol. 517, pp. 216027-216027
Closed Access | Times Cited: 7
Luyao Tian, Xia Li, Lanping Guo, et al.
Coordination Chemistry Reviews (2024) Vol. 517, pp. 216027-216027
Closed Access | Times Cited: 7
Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers
Haotian Liao, Xing Chen, Haichuan Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1747-1763
Open Access | Times Cited: 6
Haotian Liao, Xing Chen, Haichuan Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1747-1763
Open Access | Times Cited: 6
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 5
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 5
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma
Mao Zhang, Yingying Huang, Jiaomeng Pan, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2248-2269
Closed Access | Times Cited: 14
Mao Zhang, Yingying Huang, Jiaomeng Pan, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2248-2269
Closed Access | Times Cited: 14
A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma
Ying Xü, Zhuo Li, Yi Yang, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Ying Xü, Zhuo Li, Yi Yang, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma
Zhizhen Li, Qingxiang Gao, Yingjun Wu, et al.
Hepatology Communications (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Zhizhen Li, Qingxiang Gao, Yingjun Wu, et al.
Hepatology Communications (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma
Chen Sang, Yan Li, Jian Lin, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 4
Chen Sang, Yan Li, Jian Lin, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 4
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Mao Zhang, Haokai Qin, Yingcheng Wu, et al.
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 4
Mao Zhang, Haokai Qin, Yingcheng Wu, et al.
Cancer Biology and Medicine (2024), pp. 1-15
Open Access | Times Cited: 4
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma
Chunbin Zhu, Jiaqiang Ma, Kai Zhu, et al.
JHEP Reports (2023) Vol. 5, Iss. 8, pp. 100762-100762
Open Access | Times Cited: 9
Chunbin Zhu, Jiaqiang Ma, Kai Zhu, et al.
JHEP Reports (2023) Vol. 5, Iss. 8, pp. 100762-100762
Open Access | Times Cited: 9
Three‐in‐One Oncolytic Adenovirus System Initiates a Synergetic Photodynamic Immunotherapy in Immune‐Suppressive Cholangiocarcinoma
Jialun Wang, Yun Zhu, Yu Chen, et al.
Small (2023) Vol. 19, Iss. 34
Closed Access | Times Cited: 8
Jialun Wang, Yun Zhu, Yu Chen, et al.
Small (2023) Vol. 19, Iss. 34
Closed Access | Times Cited: 8
TRIB3 As an Emerging Biomarker and Potential Target for Cholangiocarcinoma: Evidence from Experiments and Bioinformatics
Chen Shen, Yijie Jiao, Yuping Lai, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Chen Shen, Yijie Jiao, Yuping Lai, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma
Yuan Liang, Qingfa Bu, Wenhua You, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167276-167276
Closed Access | Times Cited: 2
Yuan Liang, Qingfa Bu, Wenhua You, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167276-167276
Closed Access | Times Cited: 2
Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis
Yanwei Ji, Qi An, Xinyu Wen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 2
Yanwei Ji, Qi An, Xinyu Wen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 2
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning
Guangyu Ding, Weimin Tan, Youpei Lin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Guangyu Ding, Weimin Tan, Youpei Lin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches
Veronica Porreca, Cristina Barbagallo, Eleonora Corbella, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2889-2889
Open Access | Times Cited: 2
Veronica Porreca, Cristina Barbagallo, Eleonora Corbella, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2889-2889
Open Access | Times Cited: 2
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges
Dan Li, Lalitya Andaloori, Matthew Crowe, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
Dan Li, Lalitya Andaloori, Matthew Crowe, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance
Ying Xü, Zhuo Li, Yi Yang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 60, Iss. 2, pp. 715-728
Closed Access | Times Cited: 6
Ying Xü, Zhuo Li, Yi Yang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 60, Iss. 2, pp. 715-728
Closed Access | Times Cited: 6
Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13612-13612
Open Access | Times Cited: 9
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13612-13612
Open Access | Times Cited: 9
Igniting cold tumors of intrahepatic cholangiocarcinoma: An insight into immune evasion and tumor immune microenvironment
Xueyin Zhou, Bin Zhang, Jiahao Hu, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100052-100052
Open Access | Times Cited: 1
Xueyin Zhou, Bin Zhang, Jiahao Hu, et al.
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100052-100052
Open Access | Times Cited: 1
Dynamics of Liver Cancer Cellular Taxa Revealed Through Single-cell RNA Sequencing: advances and challenges
Wenxin Li, Huisi He, Hongyang Wang, et al.
Cancer Letters (2024), pp. 217394-217394
Closed Access | Times Cited: 1
Wenxin Li, Huisi He, Hongyang Wang, et al.
Cancer Letters (2024), pp. 217394-217394
Closed Access | Times Cited: 1